Evidence map›Paper›PMID 36671624›Full record

ArticleBioengineering (Basel, Switzerland)2022

Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model.

Ilenia Iaia, Virginia Brancato, David Caballero, Rui L Reis, Massimo Aglietta, Dario Sangiolo, Subhas C Kundu

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Tumor-microenvironment-on-a-chip: the construction and application.Cell communication and signaling : CCS · 2024
    Review
  3. NK cell-based tumor immunotherapy.Bioactive materials · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ilenia IaiaCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0001-9698-1402
Virginia BrancatoICVS/3B's-PT Government Associate Laboratory, 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, 4700-000 Braga, Portugal.ORCID 0000-0002-9992-4769
David CaballeroICVS/3B's-PT Government Associate Laboratory, 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, 4700-000 Braga, Portugal.ORCID 0000-0001-7930-2535
Rui L ReisICVS/3B's-PT Government Associate Laboratory, 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, 4700-000 Braga, Portugal.ORCID 0000-0002-4295-6129
Massimo AgliettaCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Dario SangioloCandiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.ORCID 0000-0002-7163-7071
Subhas C KunduICVS/3B's-PT Government Associate Laboratory, 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, 4700-000 Braga, Portugal.ORCID 0000-0002-7170-2291

Funding

Fundação para a Ciência e Tecnologia CEECIND/00352/2017Fundação para a Ciência e Tecnologia PTDC/BTM-ORG/28070/2017Fundação para a Ciência e Tecnologia PTDC/BTM-ORG/28168/2017Italian Association for Cancer Research IG-2017 n. 20259The support of EU Framework Programme for Research and Innovation H2020 on FoReCaST 668983
6 · The paper itself

Abstract

Adoptive cell therapy in solid tumors, such as melanoma, is impaired, but little is known about the role that the fibroblasts present in the tumor microenvironment could exert. However, the mechanism at play is not well understood, partly due to the lack of relevant pre-clinical models. Three-dimensional culture and microfluidic chips are used to recapitulate the dynamic interactions among different types of cells in the tumor microenvironment in controlled and physiological settings. In this brief report, we propose a reductionist melanoma-on-a-chip model for evaluating the essential role of fibroblasts in the antitumor activity of lymphocytes. To this end, 3D melanoma spheroids were monocultured and co-cultured with human dermal fibroblasts and the NK-92 cell migration towards the tumor compartment was tested in a commercially available microfluidic device. Utilizing confocal microscopy, we observed the different recruitment of NK-92 cells in the presence and absence of fibroblasts. Our results show that fibroblasts' presence inhibits immune effector recruiting by exploiting a 3D pre-clinical tumor model.

Indexed as

Adoptive cell therapymelanomatumor-on-chip

Identifiers

PMID36671624
PMCPMC9854880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.